James Budge, CFO of Hinge Health, sold shares worth approximately $317,757 on May 26, 2026, according to an SEC filing.
The transaction involved 5,907 shares of Class A Common Stock, sold at weighted average prices between $53.32 and $55.22, near the current price of $53.58.
The sales were executed under a Rule 10b5-1 trading plan adopted on June 12, 2025.
Hinge Health shares have gained 27% over the past year, with analysts remaining bullish. Eleven analysts have revised earnings estimates upward, with price targets ranging from $55 to $95.
Following the sale, Budge directly holds 445,386 shares.
In other news, Hinge Health reported strong Q1 2026 results, with EPS of $0.45 beating the $0.12 forecast, and revenue of $182 million, up 47% year-over-year.
